SEARCH

SEARCH BY CITATION

References

  • ARAUJO, R.C., SILVA, J.A., WALTHER, T., OLIVEIRA, S.M., PESQUERO, J.B. & BADER, M. (1998). Reduced hypotensive response to endotoxin in kinin B1 receptor deficient mice. Abstracts book, The 15th International Conference on Bradykinin and Related Kinins, Kinin '98, Nara, Japan, p.57.
  • BELLOMO, R. (1992). The cytokine network in the critically ill. Anaesth. Intensive. Care, 20, 288302.
  • BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev., 44, 180.
  • BOUCHARD, J.F., CHOUINARD, J. & LAMONTAGNE, D. (1998). Role of kinins in the endothelial protective effect of ischaemic preconditioning. Br. J. Pharmacol., 123, 413420.
  • BOUTHILLIER, J., DEBLOIS, D. & MARCEAU, F. (1987). Studies on the induction of pharmacological responses to des- Arg9- bradykinin in vitro and in vivo. Br. J. Pharmacol., 92, 257264.
  • CHURCHILL, L. & WARD, P.E. (1986). Relaxation of isolated mesenteric arteries by des- Arg9- bradykinin stimulation of B1 receptors. Eur. J. Pharmacol., 130, 1118.
  • DEBLOIS, D. & MARCEAU, F. (1987). The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation. Eur. J. Pharmacol., 142, 141144.
  • DELA, C.R., SUFFREDINI, A.F., PAGE, J.D., PIXLEY, R.A., KAUFMAN, N., PARRILLO, J.E. & COLMAN, R.W. (1993). Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood., 81, 33133317.
  • DEWITT, B.J., CHENG, D.Y. & KADOWITZ, P.J. (1994). Des-Arg9-bradykinin produces tone-dependent kinin B1 receptor-mediated responses in the pulmonary vascular bed. Circ. Res., 75, 10641072.
  • DRUMMOND, G.R. & COCKS, T.M. (1995a). Endothelium-dependent relaxation to the B1 kinin receptor agonist des- Arg9-bradykinin in human coronary arteries. Br. J. Pharmacol., 116, 30833085.
  • DRUMMOND, G.R. & COCKS, T.M. (1995b). Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery. Br. J. Pharmacol., 116, 24732481.
  • ELLWOOD, A.J. & CURTIS, M.J. (1997). Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfunction in guinea-pig isolated heart. Br. J. Pharmacol., 120, 10391048.
  • FEIN, A.M., BERNARD, G.R., CRINER, G.J., FLETCHER, E.C., GOOD, J.T.J., KNAUS, W.A., LEVY, H., MATUSCHAK, G.M., SHANIES, H.M., TAYLOR, R.W. & RODELL, T.C. (1997). Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). JAMA, 277, 482487.
  • FELETOU, M., LONCHAMPT, M., ROBINEAU, P., JAMONNEAU, I., THURIEAU, C., FAUCHERE, J.L., VILLA, P., GHEZZI, P., PROST, J.F. & CANET, E. (1995). Effects of the bradykinin B2 receptor antagonist S 16118 (p- guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation. J. Pharmacol. Exp. Ther., 273, 10781084.
  • FILEP, J.G., DELALANDRE, A. & BEAUCHAMP, M. (1997). Dual role for nitric oxide in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Circ. Res., 81, 840847.
  • GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184188.
  • GLAUSER, M.P. (1996). The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs, 52 Suppl 2, 917.
  • HANASAKI, K., YOKOTA, Y., ISHIZAKI, J., ITOH, T. & ARITA, H. (1997). Resistance to endotoxic shock in phospholipase A2 receptor- deficient mice. J. Biol. Chem., 272, 3279232797.
  • HOHLFELD, T., KLEMM, P., THIEMERMANN, C., WARNER, T.D., SCHROR, K. & VANE, J.R. (1995). The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br. J. Pharmacol., 116, 33093315.
  • KINUGAWA, K., SHIMIZU, T., YAO, A., KOHMOTO, O., SERIZAWA, T. & TAKAHASHI, T. (1997). Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ. Res., 81, 911921.
  • KONTOS, M.A., MAGEE, J.H. & SHAPIRO, W. (1964). General and regional circulation effects of synthetic bradykinin in man. Circ. Res., 14, 352.
  • LUSS, H., WATKINS, S.C., FREESWICK, P.D., IMRO, A.K., NUSSLER, A.K., BILLIAR, T.R., SIMMONS, R.L., DEL NIDO, P.J. & MCGOWAN, F.X.J. (1995). Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J. Mol. Cell Cardiol., 27, 20152029.
  • MARCEAU, F., HESS, J.F. & BACHVAROV, D.R. (1998). The B1 receptors for kinins. Pharmacol Rev., 50, 357386.
  • MARTICH, G.D., BOUJOUKOS, A.J. & SUFFREDINI, A.F. (1993). Response of man to endotoxin. Immunobiology., 187, 403416.
  • MENG, X., AO, L., BROWN, J.M., FULLERTON, D.A., BANERJEE, A. & HARKEN, A.H. (1997). Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock, 7, 111118.
  • MULLER, B., KLESCHYOV, A.L., MALBLANC, S. & STOCLET, J.C. (1998). Nitric oxide-related cyclic GMP-independent relaxing effect of N- acetylcysteine in lipopolysaccharide-treated rat aorta. Br. J. Pharmacol., 123, 12211229.
  • NI, A., CHAO, L. & CHAO, J. (1998). Molecular cloning and expression of rat bradykinin B1 receptor. Biochim. Biophys. Acta, 1442, 177185.
  • NICOLAU, M., FELTRIN, M.R. & REGOLI, D. (1996). Induction of bradykinin B1 hypotensive receptors in rats by lipopolysaccharide. Can. J. Physiol. Pharmacol., 74, 337340.
  • NIES, A.S., FORSYTH, R.P., WILLIAMS, H.E. & MELMON, K.L. (1968). Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys. Circ. Res., 22, 155164.
  • PESQUERO, J.B., PESQUERO, J.L., OLIVEIRA, S.M., ROSCHER, A.A., METZGER, R., GANTEN, D. & BADER, M. (1996). Molecular cloning and functional characterization of a mouse bradykinin B1 receptor gene. Biochem. Biophys. Res. Commun., 220, 219225.
  • PRUNEAU, D. & BELICHARD, P. (1993). Induction of bradykinin B1 receptor-mediated relaxation in the isolated rabbit carotid artery. Eur. J. Pharmacol., 239, 6367.
  • PRUNEAU, D., LUCCARINI, J.M., DEFRENE, E., PAQUET, J.L. & BELICHARD, P. (1996). Characterisation of bradykinin receptors from juvenile pig coronary artery. Eur. J. Pharmacol., 297, 5360.
  • RAIDOO, D.M., RAMSAROOP, R., NAIDOO, S., MULLER-ESTERL, W. & BHOOLA, K.D. (1997). Kinin receptors in human vascular tissue: their role in atheromatous disease. Immunopharmacology, 36, 153160.
  • REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 146.
  • RHALEB, N.E., DION, S., BARABE, J., ROUISSI, N., JUKIC, D., DRAPEAU, G. & REGOLI, D. (1989). Receptors for kinins in isolated arterial vessels of dogs. Eur. J. Pharmacol., 162, 419427.
  • SANTIAGO, J.A., GARRISON, E.A., CHAMPION, H.C., SMITH, R.E., DEL RIO, O. & KADOWITZ, P.J. (1995). Analysis of responses to kallidin, DABK, and DAK in feline hindlimb vascular bed. Am. J. Physiol., 269, H2057H2064.
  • UNGUREANU-LONGROIS, D., BALLIGAND, J.L., SIMMONS, W.W., OKADA, I., KOBZIK, L., LOWENSTEIN, C.J., KUNKEL, S.L., MICHEL, T., KELLY, R.A. & SMITH, T.W. (1995). Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ. Res., 77, 494502.
  • WAAGE, A., BRANDTZAEG, P., ESPEVIK, T. & HALSTENSEN, A. (1991). Current understanding of the pathogenesis of gram-negative shock. Infect. Dis. Clin. North. Am., 5, 781791.
  • WAAGE, A., BRANDTZAEG, P., HALSTENSEN, A., KIERULF, P. & ESPEVIK, T. (1989). The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med., 169, 333338.
  • WHALLEY, E.T., SOLOMON, J.A., MODAFFERI, D.M., BONHAM, K.A. & CHERONIS, J.C. (1992). CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock. Agents. Actions. Suppl., 38, 413420.
  • WILSON, D.D., DE GARAVILLA, L., KUHN, W., TOGO, J., BURCH, R.M. & STERANKA, L.R. (1989). D-Arg-[Hyp3-D-Phe7]-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock. Circ. Shock, 27, 93101.